In the previous prospectus $5M was supposed to take AMD through in vivo proof of concept. Now, $4M is supposed to take AMD through in vivo proof of concept, IND and start of a clinical trial.
I know that being critical of management is not popular on HC but, come on, this is just finger in the wind budgeting and how can that be good management?
Updated listing price, page-26
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)